Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PHAT | STTK |
|---|---|---|
| Price | $6.81 | $5.66 |
| Change today | ▲ 0.44% | ▼ 3.50% |
| Market cap | $550.94M | $567.55M |
| Return, 3 months | -44.0% | -19.6% |
| Return, year to date | -59.0% | +54.9% |
| Return, 1 year | -38.4% | +136.6% |
| P/E (TTM) | -5.4 | -12.9 |
| P/B | -1.6 | 2.7 |
| P/E percentile vs own 5y | 6th | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +88.0% | – |
| Net profit growth (YoY) | +76.8% | -21.6% |
| Gross margin | 82.9% | – |
| Operating margin | -17.0% | -5,578.6% |
| Net margin | -41.3% | -5,256.8% |
| Return on equity | – | -39.2% |
| Analyst target vs. price | +183.3% | +180.5% |
| Analyst buy share | 86% | 100% |
| RSI (14) | 33 | 35 |
| 30-day volatility | 58.3% | 56.1% |
| Max drawdown, 1 year | -62.9% | -50.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
